Author
Listed:
- Yi Wei
(Sichuan University)
- Meiyi Yang
(University of Electronic Science and Technology of China)
- Meng Zhang
(Sanya People’s Hospital)
- Feifei Gao
(Sichuan University)
- Ning Zhang
(Henan Provincial People’s Hospital)
- Fubi Hu
(The First Affiliated Hospital of Chengdu Medical College)
- Xiao Zhang
(Leshan People’s Hospital)
- Shasha Zhang
(Guizhou Provincial People’s Hospital)
- Zixing Huang
(Sichuan University)
- Lifeng Xu
(Quzhou People’s Hospital)
- Feng Zhang
(Quzhou People’s Hospital)
- Minghui Liu
(University of Electronic Science and Technology of China)
- Jiali Deng
(University of Electronic Science and Technology of China)
- Xuan Cheng
(University of Electronic Science and Technology of China)
- Tianshu Xie
(University of Electronic Science and Technology of China)
- Xiaomin Wang
(University of Electronic Science and Technology of China)
- Nianbo Liu
(University of Electronic Science and Technology of China)
- Haigang Gong
(University of Electronic Science and Technology of China)
- Shaocheng Zhu
(Henan Provincial People’s Hospital)
- Bin Song
(Sichuan University
Sanya People’s Hospital)
- Ming Liu
(Quzhou People’s Hospital
University of Electronic Science and Technology of China)
Abstract
Diagnosing liver lesions is crucial for treatment choices and patient outcomes. This study develops an automatic diagnosis system for liver lesions using multiphase enhanced computed tomography (CT). A total of 4039 patients from six data centers are enrolled to develop Liver Lesion Network (LiLNet). LiLNet identifies focal liver lesions, including hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), metastatic tumors (MET), focal nodular hyperplasia (FNH), hemangioma (HEM), and cysts (CYST). Validated in four external centers and clinically verified in two hospitals, LiLNet achieves an accuracy (ACC) of 94.7% and an area under the curve (AUC) of 97.2% for benign and malignant tumors. For HCC, ICC, and MET, the ACC is 88.7% with an AUC of 95.6%. For FNH, HEM, and CYST, the ACC is 88.6% with an AUC of 95.9%. LiLNet can aid in clinical diagnosis, especially in regions with a shortage of radiologists.
Suggested Citation
Yi Wei & Meiyi Yang & Meng Zhang & Feifei Gao & Ning Zhang & Fubi Hu & Xiao Zhang & Shasha Zhang & Zixing Huang & Lifeng Xu & Feng Zhang & Minghui Liu & Jiali Deng & Xuan Cheng & Tianshu Xie & Xiaomin, 2024.
"Focal liver lesion diagnosis with deep learning and multistage CT imaging,"
Nature Communications, Nature, vol. 15(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51260-6
DOI: 10.1038/s41467-024-51260-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51260-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.